Podiatrists in Kenosha, WI Accepting Medicare

25 Podiatrists found. Showing 21 - 25

H.r. Reinherz Dpm,sc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 6801 Sheridan Rd, Kenosha, WI 53143 Phone: 262-654-2801

Foot & Ankle Health Care Sc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6707 39 Avenue, Kenosha, WI 53142 Phone: 262-654-9181    Fax: 262-654-3330

Dr. William Allen Yoder, DPM Podiatrist - Foot & Ankle Surgery Medicare: May Accept Medicare Assignments Practice Location: 3535 30th Ave, Suite 203, Kenosha, WI 53144 Phone: 262-657-6104    Fax: 262-657-6194

Dr. John L Bostanche, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 6123 Green Bay Rd, Ste 100, Kenosha, WI 53142 Phone: 262-657-3668    Fax: 262-652-0564

Weil Foot And Ankle Institute Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 10105 74th St Ste 101, Kenosha, WI 53142 Phone: 847-390-7666    Fax: 847-390-9345

News Archive

Men's flashy spending may work for the short term but not for marriage

New research by faculty at Rice University, the University of Texas-San Antonio (UTSA) and the University of Minnesota finds that men's conspicuous spending is driven by the desire to have uncommitted romantic flings. And, gentlemen, women can see right through it.

Botox approved as treatment for severe underarm sweating

The FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as "primary axillary hyperhidrosis" that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes.

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with metastatic renal cell carcinoma (RCC).

Study finds association between personality, cognitive ability and neuroendocrinal dysfunction in exhaustion syndrome

Exhaustion syndrome, also called burnout and exhaustion depression, leaves objectively measurable changes in the brain including reduced activity in the frontal lobes and altered regulation of the stress hormone cortisol. This is shown in a new dissertation from Umeå University in Sweden.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)